Should You Buy Injective in 2025?

Why trust HelloSafe?

At HelloSafe, our expert has been monitoring the evolution of Injective cryptocurrency for over three years. Every month, hundreds of thousands of users in India trust us to analyze market trends and identify the best investment opportunities. Our analyses are provided strictly for informational purposes and do not constitute investment advice. In line with our ethical guidelines, HelloSafe has never purchased Injective or received any compensation from entities associated with its ecosystem.

Injective in brief

How much does 1 Injective cost?

The price of Injective is on the rise this week. Currently, INJ is trading at ₹1,019.12, with a 24-hour gain of +4.63% despite a -15% change over the past week. The market capitalization stands at approximately ₹101.8 billion, making INJ the 61st largest cryptocurrency by market cap, with around 99.97 million INJ tokens in circulation.

Over the past three months, average daily trading volume reached ₹7.54 billion, and INJ holds a modest 0.06% share of the total crypto market. Rapid price swings are common with Injective, so investors should weigh both the opportunities and risks before making a decision.

Our full review of the Injective crypto

Have we reached a pivotal moment for Injective? Our in-depth review of the latest trends, combined with a rigorous 3-year performance analysis, leverages proprietary algorithms that synthesize on-chain indicators, technical signals, market data, and competitive dynamics. So, why could Injective emerge in 2025 as a strategic point of entry into the DeFi and AI-integrated blockchain ecosystem?

Recent Performance and Market Context

Recent Price Evolution

Injective (INJ) entered June 2025 trading at $12.21, reflecting a robust 4.63% daily gain but a correction of 15% over the past week from $14.93. Despite retracing sharply—down 76.8% from its all-time high of $52.75 reached in March 2024—Injective stands out for the resilience shown in its on-chain activity and fundamental metrics. This sharp volatility is not isolated but reflective of the broader digital assets sector, disrupted by shifting liquidity cycles and periodic de-risking following parabolae in prices.

Recent Positive Events

• INJ 3.0 release implemented an accelerated token burn, increasing the deflationary pressure.
• Altaris mainnet upgrade enhanced the burn auction mechanisms.
• Major institutional developments, with Deutsche Telekom joining as validator, and 21Shares listing INJ ETP on Euronext, expanding access for traditional investors.
• AI agent SDK launch positioned Injective at the frontier of automated DeFi and on-chain AI finance.
• Cross-chain growth, adding EVM-native support and bridges to 23+ networks, including Ethereum and Solana.

Favorable Macro/Sector Backdrop

Recent macro signals point to an accelerating institutional embrace of blockchain infrastructure. As financial entities seek DeFi exposure and tokenization of real-world assets (RWA), protocols able to combine speed, low fees, and compliance potential are positioned for gains. Furthermore, the ongoing global search for high-yield asset classes in a lower-rate environment enhances relative demand for protocols like Injective, which embed staking returns and deflationary logic.

Technical Analysis

On-Chain and Chart Indicators

• RSI (14D): Neutral at 49.6, suggesting neither overbought nor oversold conditions and leaving room for accumulation.
• MACD: Slightly negative at 0.062, highlighting previous profit-taking, yet the overall reset creates a constructive setup for incoming buyers.
• Price vs. Moving Averages:
• Trading below the 20-day SMA ($12.80) but above the 50-day ($11.52) and 100-day ($10.52) SMAs—classic signs of a market stabilizing after capitulation, with potential for upside momentum resuming.
• The 200-day SMA ($16.22) represents the primary resistance and a high-conviction upside target should momentum confirm.

Support & Reversal Points

• Key short-term support: $11.69. This has held despite broader weakness, highlighting strong hands accumulating.
• Breakout resistance: $12.33 (recent high). Sustained closes above this level could confirm trend reversal.
• Major resistance: $16.22. A break above this level would structurally validate the next bull phase.

Momentum and Structure Outlook

The present confluence of neutral oscillators and compressed price action above higher timeframe supports positions Injective as a candidate for a sharp upside move as soon as buying pressure returns. The “washout” from 2024 highs appears largely digested, with volatility set to revert higher in either direction; the favorable asymmetry justifies an active approach to accumulation by risk-aware investors.

Fundamental Analysis

Ecosystem Growth & Partnerships

• User growth: Daily active addresses have quadrupled from 9,300 to 40,600 in the past six months, a clear indicator of strengthening network effects.
• Project density: Over 100 dApps have launched on Injective, establishing its role as a DeFi innovation hub.
• Institutional/Strategic partnerships: Deutsche Telekom as validator, integrations with Google Cloud and Coinbase Institutional, and support for BlackRock’s BUIDL Fund tokenization.
• Staking engagement: Over 51.5 million INJ staked—up more than 10% in 2024—demonstrating investor confidence and locking in supply.

Valuation Metrics

• Market Cap: $1.22 billion, reflecting deep liquidity and relative undervaluation when contextualized against historical highs and competitors with similar protocol usage metrics.
• Token Dynamics: Nearly entire supply (99.97M INJ) is in circulation, eliminating overhang from emissions.
• Fully Diluted Valuation: Aligned closely with market cap, minimizing future inflation risk.
• Burn Rate: Highest industry burn ratio; over 6 million tokens permanently removed via weekly auctions.

Structural Strengths

• Technical edge: Sub-second block times (0.64s), 25,000+ TPS capacity, and near-instant, sub-cent transaction fees.
• Community traction: Active governance, community engagement, and developer incentives (dApp creators receive 40% of network fees).
• Innovation premium: First-mover in AI agent SDK, embedding AI automation in on-chain financial workflows.
• Diverse revenue: Protocol splits network revenues between burn (deflation) and ecosystem growth, favoring long-term composability.

Volume & Liquidity

• 24h Trading Volume: $90.36 million—a strong >7% volume/market cap ratio, underpinning reliable price discovery and entry/exit liquidity for sizable positions.
• Dominance/Ranking: Now firmly a top-70 asset, with sustainable trading activity and global exchange support.

Catalysts and Positive Prospects

• Ongoing protocol upgrades: Upcoming network “Altaris” and INJ 4.0 will further streamline user experience and developer functionality.
• AI integration: Unmatched in the space, likely to attract DeFi, fintech, and AI/robotics capital in the next business cycle.
• Institutional flows: Continued validator growth and product launches (INJ ETP) set to channel new liquidity.
• Deflation and scarcity: Recurring burns, alongside rising staking, place persistent upward pressure on long-term price formation.
• Cross-chain and RWA leadership: Injective is a leading platform for on-chain real-world assets and institutional DeFi.

Investment Strategies by Horizon

Short-term (Weeks to Months)

• Price oscillates around multi-month support ($11.69–$12.33), offering an efficient entry zone for tactical trades or DCA (dollar-cost averaging) strategies.
• Ideal positioning before material protocol upgrades or if technical breakout above $12.33 is confirmed.
• Stop-loss and active management remain key due to sector-wide volatility.

Medium-term (6–24 Months)

• Anticipate compounding effects from active dApp launch momentum, user growth, cross-chain integrations, and institutional validation (Euronext product, validator onboarding).
• Entry at current valuations allows asymmetric exposure should a post-capitulation recovery cycle unfold.
• Monitor staking participation and burn metrics for confirmation of durable supply constriction.

Long-term (2–5 Years)

• Buy-and-hold allocations appear fundamentally justified given Injective’s ability to secure DeFi, RWA, and AI integration market share.
• Deflationary tokenomics, continued burn events, and high-profile backing (Binance, Pantera, Jump, Mark Cuban) combine for deep-rooted value creation.
• Robust developer ecosystem, high technical throughput, and regulatory adaptability further reinforce long-horizon conviction.

Price Forecast for Injective (INJ)

Is Now the Right Time to Buy Injective?

Summary of Key Strengths:

• Rapidly expanding user base and ecosystem with 100+ active dApps and 2B+ transactions processed.
• Institutional partnerships and ETP listings advancing market access and credibility.
• Deflationary model via industry-leading token burn and high staking participation ensuring sustainable supply dynamics.
• Accelerated innovation through AI/automation and early-mover advantage in RWA and cross-chain integrations.
• Deep liquidity and consistent high trading volumes enabling professional-grade allocations.
• Strong technical foundation: fast finality, low fees, global reach, and a track record of major network upgrades.

Injective’s fundamentals, network effects, and upcoming protocol improvements strongly justify renewed attention at present levels. The prevailing confluence of growth, deflationary supply, and cutting-edge innovation aligns favorably for return-seeking investors. With sector leadership in DeFi, AI, and RWA, Injective could well initiate its next powerful uptrend. While volatility is inherent, the current market structure, historical burn rates, and ecosystem development suggest that Injective presents an exceptionally compelling opportunity for investors aiming to capture the upside potential of next-generation blockchain finance.

Injective remains a high-volatility asset offering excellent opportunities for dynamic investment, but demanding rigorous risk management. The recent price reset underlines Injective’s ability to deliver sharp, powerful moves, while the evolving macro and ecosystem context reinforce the importance of selectivity. The critical technical levels to monitor are $11.69 as immediate support and $16.22 as the major resistance. The upcoming protocol update in Q2 2025 could well serve as a decisive catalyst for INJ’s next significant move.

How to buy Injective?

Purchasing the cryptocurrency Injective (INJ) online is both straightforward and secure when using a regulated platform. As an Indian investor, you have access to two major methods: spot buying (direct purchase of the coin) and crypto CFD trading (speculating on price movements without owning actual tokens). Spot buying suits those who want real ownership, while CFD trading is geared towards traders seeking exposure and leverage. Each method has its own fee structure and risk profile, so choosing the right one is essential. To help you compare regulated Indian and global platforms, a detailed comparative table is available further down this page.

Spot Purchase of Injective

Buying INJ “on the spot” means you’re actually acquiring real coins, which you can store in your own crypto wallet. Typically, Indian exchanges charge a fixed commission per transaction, often between 0.1% and 0.25%, plus a small INR-based transaction fee.

Example

Suppose INJ is priced at $12.21 (about ₹1,018 per coin at an exchange rate of $1 = ₹83.4). With a 1,000 €/₹90,000 investment, you could buy roughly 88 INJ coins (excluding possible INR-to-USD conversion). With around ₹500 in transaction fees, you’d directly own these tokens in your account or wallet.

✔️ Gain Scenario

If INJ rises by 10%, your holding value increases to ₹99,000. That’s a ₹9,000 gross profit—+10% on your investment.

Trading via CFD

CFD (Contract for Difference) trading lets you speculate on INJ price movements without owning the underlying asset. This method is offered by regulated CFD brokers and is attractive for its leverage but involves higher risks. Instead of a direct commission, you pay a spread (the difference between buy and sell price) plus an overnight financing fee if you hold your position beyond a day.

Example

You decide to use ₹90,000 (about 1,000 €) to open a CFD position on INJ with 5x leverage. This means you have ₹450,000 in market exposure. If INJ’s price rises by 8%, your CFD position returns 8% × 5 = 40%. That’s a gain of ₹36,000 (excluding spreads/fees), compared to ₹90,000 invested.

✔️ Gain Scenario

If INJ moves up 8%, your leveraged position results in a 40% profit—₹36,000 on your ₹90,000 initial margin (before fees).

Final Guidance

Before investing in Injective, it’s crucial to compare platform fees, transaction conditions, and user protections, as these vary and can impact your returns. Your choice—spot buying or CFDs—should align with your risk tolerance and investment experience. For more guidance, refer to our in-depth platform comparison further down this page to find the solution best suited to your needs.

Our 7 tips for buying Injective

The latest news about Injective

Injective’s daily active user base saw robust growth, quadrupling over the last six months.
This acceleration—from 9,300 in November 2024 to 40,600 in May 2025—demonstrates increasing network utility and signals persistent user engagement, an essential marker for long-term ecosystem health. Rising activity on the Injective blockchain may facilitate greater liquidity and product experimentation, outcomes especially relevant for the Indian market where DeFi adoption rates are on the rise and users increasingly seek robust, scalable alternatives to legacy financial systems.

Native Ethereum Virtual Machine (EVM) integration broadens Injective’s cross-chain appeal, driving new use cases and development.
With EVM compatibility now live, developers in India can seamlessly port Ethereum-based decentralized applications onto Injective’s high-throughput chain, accelerating time-to-market for local projects and making the network more accessible for Indian Web3 builders, who form a rapidly expanding cohort both domestically and in the global blockchain developer landscape.

Institutional engagement is intensifying, as seen with major validators and a new exchange-traded product listing.
The entry of Deutsche Telekom as a validator and the launch of the 21Shares INJ ETP on Euronext underscore growing confidence among institutions in Injective’s long-term viability. Given India’s burgeoning interest in regulated crypto exposure and financial products, these endorsements may inspire similar local offerings or strategic partnerships with Indian institutions and regulated platforms, boosting legitimacy and adoption potential.

Staking participation rose to 51.5 million INJ, reflecting robust community trust and a maturing token economy.
This recent milestone—a 10.34% increase in tokens staked during 2024—suggests deepening user commitment and the growing attractiveness of passive income streams amid volatile markets. For Indian investors, where staking and yield-generating products are in demand, Injective’s staking growth and the appeal of its deflationary mechanics offer a positive signal for both retail and professional market participants.

The accelerated weekly token burn program has now retired more than 6 million INJ, supporting a deflationary model that appeals to value-focused investors.
Through protocol-driven burn auctions, more than 6% of the total supply has been permanently removed, ensuring that increasing usage directly benefits holders by reducing available supply. In the context of India’s regulatory trajectory—where projects with transparent, mathematically enforced scarcity mechanisms attract heightened institutional scrutiny and favor—Injective’s approach fortifies its standing among investors seeking token models with programmed, dependable value accrual.

FAQ

P. Laurore

Finance expert

Co-founder of HelloSafe and holder of a Master's degree in finance, Pauline has recognised expertise in personal finance, which she uses to help users better understand and optimise their financial choices. At HelloSafe, Pauline plays a key role in designing clear, educational content on savings, investments and personal finance. Passionate about financial education, Pauline strives, with every piece of content she oversees, to provide reliable, transparent and unbiased information for independent and informed financial management. To this end, she has tested over 100 trading platforms to help internet users make the right choices.

Ask a question, an expert will answer